Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology
- PMID: 38993658
- PMCID: PMC11235578
Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology
Abstract
NTX is FDA-approved for opiate and alcohol use disorders as anti-craving agent. It has been used successfully off-label in other psychiatric indications. Here, we shed some light on these while examining the extant evidence.
Keywords: SIBs; SUDs; binge eating; naltrexone; obesity; paraphilia; pathologic gambling.
Copyright © 1964–2024 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States.
Similar articles
-
Sustained-release naltrexone for opioid dependence.Cochrane Database Syst Rev. 2025 May 9;5(5):CD006140. doi: 10.1002/14651858.CD006140.pub3. Cochrane Database Syst Rev. 2025. PMID: 40342086 Review.
-
Naltrexone depot formulations for opioid and alcohol dependence: a systematic review.CNS Neurosci Ther. 2011 Dec;17(6):629-36. doi: 10.1111/j.1755-5949.2010.00194.x. CNS Neurosci Ther. 2011. PMID: 21554565 Free PMC article.
-
Opioid antagonists for alcohol dependence.Cochrane Database Syst Rev. 2005 Jan 25;(1):CD001867. doi: 10.1002/14651858.CD001867.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2010 Dec 08;(12):CD001867. doi: 10.1002/14651858.CD001867.pub3. PMID: 15674887 Updated.
-
OPRM1 rs1799971 Polymorphism Predicts Differential Response to Extended-Release Naltrexone in Alcohol Use Disorder: The Interplay of Genetics and Motivation.Psychopharmacol Bull. 2025 Jul 4;55(4):68-78. Psychopharmacol Bull. 2025. PMID: 40630969
-
Off-label Use of Lamotrigine and Naltrexone in the Treatment of Ketamine Use Disorder: A Case Report.J Addict Med. 2025 Jan-Feb 01;19(1):112-114. doi: 10.1097/ADM.0000000000001359. Epub 2024 Aug 5. J Addict Med. 2025. PMID: 39101571
Cited by
-
Association of OPRD1 Gene Variants with Changes in Body Weight and Psychometric Indicators in Patients with Eating Disorders.J Clin Med. 2024 Sep 1;13(17):5189. doi: 10.3390/jcm13175189. J Clin Med. 2024. PMID: 39274402 Free PMC article.
-
Psychopharmacology: The 'Combo Pills'-Did it find its way into Practice?Psychopharmacol Bull. 2025 Feb 3;55(2):80-84. Psychopharmacol Bull. 2025. PMID: 39935667
References
-
- Naguy A, Badr BHM. Buprobion-Myth-Busting. CNS Spetr . 2021;27(5):545–546. - PubMed
-
- Naguy A. Viewpoint: Borderline Personality Disorder-Light At the End of the Tunnel. Isr J Psychiatry Relat Sci . 2020;57(1):41–43.
-
- Elchaar GM, Maisch NM, Augusto LMG et al. Efficacy and Safety of Naltrexone Use in Pediatric Patients with Autistic Disorder. Ann Pharmacother . 2006;40(6):1086–1095. - PubMed
-
- Bartley CA, Bloch MH. Meta-Analysis: Pharmacological Treatment of Pathological Gambling. Expert Rev Neurother . 2013;13:887–894. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources